Product Information
VANCOMYCIN 250 MG/5 ML ORAL SOL is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.7018 per ML under NDC 62559083055. Its NADAC has been published 142 times since Jan 17, 2024.
FDA first approved this application before 1982.
Strength
250 mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559083055
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA061667FDA Approved
Before 1982
On Market Since
9/9/2019
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN 250 MG/5 ML ORAL SOL has been published 142 times since Jan 17, 2024, and over the history we have for it it has declined 20.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7018 per ML |
|---|---|
| All-time high | $1.0320 (May 15, 2024) |
| All-time low | $0.5897 (Apr 23, 2025) |
| 52-week high | $0.7438 |
| 52-week low | $0.5926 |
| Median price | $0.6469 |
| Average price | $0.6974 |
| Largest weekly change | +28.3% (Mar 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vancomycin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Glycopeptide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANCOMYCIN 250 MG/5 ML ORAL SOL?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN 250 MG/5 ML ORAL SOL, manufactured by ANI Pharmaceuticals, Inc., is $0.7018 per ML (NDC 62559083055), effective Sep 30, 2026.
How has the price of VANCOMYCIN 250 MG/5 ML ORAL SOL changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN 250 MG/5 ML ORAL SOL has declined 20.7%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN 250 MG/5 ML ORAL SOL?
Since Jan 17, 2024, the NADAC for VANCOMYCIN 250 MG/5 ML ORAL SOL has ranged from a low of $0.5897 (Apr 23, 2025) to a high of $1.0320 (May 15, 2024), with a median of $0.6469 per ML.
Are there cheaper alternatives to VANCOMYCIN 250 MG/5 ML ORAL SOL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VANCOMYCIN 250 MG/5 ML ORAL SOL in a comparable dosage form, but none are currently priced below it.
Who manufactures VANCOMYCIN 250 MG/5 ML ORAL SOL?
VANCOMYCIN 250 MG/5 ML ORAL SOL (NDC 62559083055) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.